Allen Frances shows us how to adjust our therapeutic approach for problems that are simple and those a bit more complex.CME: Take the CME Post-Test for this EpisodePublished On: 12/16/2024Duration: 21 minutes, 45 secondsChris Aiken, Allen Frances, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

We talk with Nick Rosenlicht, MD about what’s gone wrong in the mental health care system.CME: Take the CME Post-Test for this EpisodePublished On: 12/09/2024Duration: 23 minutes, 57 secondsChris Aiken, Nicholas Rosenlicht, and Kellie Newsome, PMHNP have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Discover the ins and outs of treating ADHD in the context of bipolar disorder. Experts discuss the risks of stimulant medications and unveil safer alternatives like armadaphinol and clonidine. Dive into the intriguing debate over non-stimulants and their mixed results for bipolar patients. Learn about the promising role of omega-3 fatty acids and even probiotics in symptom relief. The emphasis is on mood stabilization before addressing ADHD, shedding light on the challenges and possibilities in this complex treatment landscape.

Discover the delicate balance needed when treating ADHD in individuals with bipolar disorder. The discussion includes the potential risks of stimulant medications and their neurotoxic effects, along with effective non-stimulant alternatives. Insights into various medications like modafinils, alpha agonists, and lithium reveal their impact on mood stabilization. Learn about the importance of careful treatment strategies that prioritize mental well-being while effectively managing symptoms.

The podcast explores the intricate overlap between bipolar disorder and ADHD, using a real-life case study to illustrate diagnostic challenges. Listeners learn about the need for precision in identifying these conditions, especially when considering treatment options like stimulant medications. A quiz is introduced to help understand affective temperaments linked to both disorders. The discussion includes a five-step guide for diagnosing ADHD in adults with bipolar symptoms, emphasizing the importance of assessing mood episodes and childhood history.

Nassir Ghaemi, a prominent figure in bipolar research and leader at the Psychopharmacology Consultation Clinic, dives into the intricacies of psychiatric diagnoses. He discusses the vital role of psychotherapy in treating bipolar disorder and critiques the current DSM approach. Ghaemi examines the implications of adult ADHD diagnoses, emphasizing the need to consider co-occurring conditions. He also calls for a reevaluation of personality disorder classifications, specifically borderline personality disorder, to improve treatment outcomes.

Discover the long-term benefits of lithium as a mood stabilizer, emphasizing the importance of tracking mood changes over time. Dive into the complexities of managing bipolar disorder with Lamotrigine and the misconceptions surrounding sleep medications. Learn about the difference between affective instability and rapid cycling, and why patients often misunderstand their mood patterns. Finally, explore effective methods for assessing medication responses, highlighting the value of input from patients and their families.

Discover innovative strategies for treating alcohol use disorder with a new drug combination that shows promise for those with co-occurring PTSD. Delve into the complexities of stimulant dosing in ADHD, balancing efficacy and side effects. Learn about a study unveiling that high-dose amphetamines may not help with ADHD symptoms in patients with cannabis use disorder. Plus, examine the surprising results of reducing antipsychotic doses in schizophrenia patients, raising questions about optimal treatment approaches. It's a blend of research and real-world application!

Recent research reshapes our understanding of lithium, suggesting it may not cause weight gain and could even aid in weight loss. Discover the promising role of lumateperone in treating major depression, especially for patients unresponsive to standard treatments. The effectiveness of lavender extract, Silexan, is also explored for anxiety relief. Additionally, a comparison of S-ketamine and quetiapine XR sheds light on options for treatment-resistant depression. These insights could change clinical practices in managing mood disorders.

Discover the latest breakthroughs in treating resistant depression, including the promising role of Transcranial Magnetic Stimulation (TMS) compared to traditional methods. Explore the alarming statistics on mortality rates linked to benzodiazepine withdrawal, highlighting severe risks for discontinuing users. The discussion also covers the emotional complexities of withdrawal, emphasizing compassion in care. Finally, learn about insights from a long-term study that stresses careful management during benzodiazepine tapering.